Moon Lander Crisis, Invisible TV Magic, Cancer Game-Changer

Just reporting the facts.

Top Stories

If you no longer wish to receive the latest, no-spin news updates from Centrist Chronicle, click here to unsubscribe


An ambitious robotic lunar expedition, funded by NASA and designed to mark America's return to the lunar surface after a hiatus since 1972, now faces uncertainty due to a fuel leak. This complication emerged soon after the privately operated spacecraft's launch was completed.

The towering Vulcan Centaur rocket, a 202-foot marvel crafted by United Launch Alliance, soared into the skies from Cape Canaveral in Florida. It triumphantly dispatched the Peregrine moon lander, a creation of Astrobotic Technology, on its lunar journey. However, about seven hours into its voyage, a glitch in Peregrine's propulsion system caused a critical fuel depletion. This mishap hampered the spacecraft's ability to align its solar panel toward the sun for essential power. The Peregrine lander, apart from carrying scientific instruments from NASA, also had on board the earthly remains sent by two space burial enterprises. The lander, which was initially slated to land on the moon on February 23, now faces an uncertain future.

This mission, Peregrine, stood as the pioneering venture under NASA's Commercial Lunar Payload Services initiative launched in 2018. This program has allocated multi-billion-dollar contracts to private entities for lunar landings. Following in the footsteps of Peregrine, Intuitive Machines, a company based in Houston, is gearing up to send its lander to the moon next month, using a SpaceX rocket.


For many years, transparent display prototypes have captivated audiences at the CES event, serving as a testament to the impressive technology of OLED panels. This year, LG is taking a significant leap by introducing a tangible transparent TV that will be available for purchase. The release date is yet to be determined, and it's expected to be priced steeply.

At CES 2024, LG unveiled the OLED Signature T (the 'T' likely refers to 'transparent'). The showcased model in Las Vegas is not the final version. The size of the display, a striking 77 inches, is set, but LG is still considering whether to include the accompanying furniture shown in promotional images as part of the package or offer it separately.


Johnson & Johnson announced on Monday its plans to acquire pharmaceutical company Ambrx Biopharma for a total of $2 billion. This strategic move is aimed at enhancing Johnson & Johnson's portfolio with a new range of specialized cancer treatments. These treatments are part of a category of targeted oncology drugs that have been garnering attention across the pharmaceutical industry.

The deal entails Johnson & Johnson offering $28 for each share of Ambrx, which is approximately a 105% increase over the company's most recent closing stock price. Following this announcement, Ambrx's shares experienced a significant rise, reaching $27.24 during premarket trading sessions.

Ambrx is at the forefront of developing a series of treatments known as antibody-drug conjugates (ADCs). ADCs are innovative in their approach to cancer treatment, often likened to "guided missiles" by medical researchers. They are designed to precisely target cancerous cells while ensuring minimal harm to healthy tissues.